Australia markets closed

Cellectar Biosciences Inc (NV4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.8800-0.1000 (-3.36%)
At close: 08:08PM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
9,565
19,866
35,704
57,165
Total cash
9,565
19,866
35,704
57,165
Other current assets
888.225
663.243
867.485
774.432
Total current assets
10,453
20,530
36,571
57,940
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,477
1,672
1,094
1,042
Accumulated depreciation
-884.909
-692.534
-544.776
-403.673
Net property, plant and equipment
1,593
978.975
549.135
638.347
Other long-term assets
29.78
81.214
81.214
81.214
Total non-current assets
1,622
1,060
630.349
719.561
Total assets
12,076
21,590
37,202
58,659
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,620
2,558
1,415
1,429
Accrued liabilities
1,490
2,004
1,936
1,164
Other current liabilities
3,700
0.443
-0.086
0.197
Total current liabilities
12,938
5,529
3,990
3,563
Non-current liabilities
Total non-current liabilities
494.003
552.981
166.292
301.74
Total liabilities
13,432
6,082
4,157
3,865
Stockholders' equity
Common stock
6,060
1,382
1,382
20,036
Retained earnings
-217,483
-179,499
-150,898
-126,775
Total stockholders' equity
-1,356
15,508
33,045
54,795
Total liabilities and stockholders' equity
12,076
21,590
37,202
58,659